EnWave Corporation (TSX-V: ENW) has signed an agreement with Saskatchewan Research Council (SRC) to install their freezeREV in-vial pharmaceutical dehydration technology for animal vaccine testing at the SRC Fermentation Pilot Plant in Saskatoon, Saskatchewan. SRC scientists will conduct a series of tests using two proprietary Escherichia coli ("E.coli") vaccines for swine to determine the potential benefits of EnWave's dehydration technology over the current freeze drying method.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About EnWave
Using proprietary technologies developed in conjunction with the University of British Columbia, EnWave is focused on the development of new methods of dehydrating food and biological materials using Radiant Energy Vacuum technology under its nutraREVTM, powderREV, bioREVTM and freezeREV brands. REV technology combines microwave energy transfer under vacuum to dehydrate and alter structures and drive chemical reactions, thereby creating unique product characteristics for both food products and medical applications that include fruit, vegetables, probiotics, enzymes, proteins, food cultures, vaccines and antibodies.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
